Cited by 126Neuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology ResearchTryptophan and brain disorders

Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus

Open access
Prieto, G. Aleph, Snigdha, Shikha, Baglietto-Vargas, David, Smith, Erica D., Berchtold, Nicole C., Tong, Liqi, Ajami, Dariush, LaFerla, Frank M. +2 more·2015·Proceedings of the National Academy of Sciences

Abstract

Significance: There is a growing understanding that inflammation impairs synaptic plasticity and cognition and that the aged brain has an elevated sensitivity to cognitive impairment by the proinflammatory cytokine interleukin 1β (IL-1β). IL-1β activates different pathways via AcP (proinflammatory) or AcPb (prosurvival) IL-1 receptor subunits. This study demonstrates that the IL-1 receptor subunit system undergoes an age-dependent reconfiguration in hippocampal synapses. This previously undescribed reconfiguration, characterized by an increase in the AcP/AcPb ratio, is responsible for potentiating impairments of synaptic plasticity and memory by IL-1β. Our data reveal a previously unidentified mechanism that explains the age-related vulnerability of hippocampal function to impairment by inflammation and adds another dimension beyond glia to understanding how inflammation causes cognitive decline in aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1514486112

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. [14]Cortese GP, Barrientos RM, Maier SF, Patterson SL (2011) Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes. J Neurosci 31(11):4274 -4279.
  2. [15]Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10(4):217 -224.
  3. [16]Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117(14):3720 -3732.
  4. [17]Thomas C, Bazan JF, Garcia KC (2012) Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol 19(4):455 -457.
  5. [18]Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z (1997) MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7(6):837 -847.
  6. [20]Lu HL, et al. (2008) A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687. Mol Immunol 45(5):1374 -1384.
  7. [21]Smith DE, et al. (2009) A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity 30(6):817 -831.
  8. [22]Huang Y, Smith DE, Ibáñez-Sandoval O, Sims JE, Friedman WJ (2011) Neuron-specific effects of interleukin-1 β are mediated by a novel isoform of the IL-1 receptor accessory protein. J Neurosci 31(49):18048 -18059.
  9. [24]Hein AM, et al. (2010) Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav Immun 24(2):243 -253.
  10. [25]Friedman WJ (2001) Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp Neurol 168(1):23 -31.
  11. [26]Docagne F, et al. (2005) Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation. Eur J Neurosci 21(5):1205 -1214.
  12. [27]Smith ED, et al. (2014) Rapamycin and interleukin-1 β impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy. J Biol Chem 289(30):20615 -20629.
  13. [29]Tong L, et al. (2012) Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1 β via p38 mitogen-activated protein kinase. J Neurosci 32(49):17714 -17724.
  14. [30]Park H, Poo MM (2013) Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14(1):7 -23.
  15. [31]Gardoni F, et al. (2011) Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1 β and NMDA stimulation. J Neuroinflammation 8(1):14.
  16. [32]Wilhelm BG, et al. (2014) Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344(6187):1023 -1028.
  17. [33]Lu W, et al. (2001) Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29(1):243 -254.
  18. [34]Musleh W, Bi X, Tocco G, Yaghoubi S, Baudry M (1997) Glycine-induced long-term potentiation is associated with structural and functional modifications of alphaamino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors. Proc Natl Acad Sci USA 94(17):9451 -9456.
  19. [35]Jurado S, et al. (2013) LTP requires a unique postsynaptic SNARE fusion machinery. Neuron 77(3):542 -558.
  20. [37]Oh MC, Derkach VA (2005) Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII. Nat Neurosci 8(7):853 -854.
  21. [38]Fortin DA, et al. (2010) Long-term potentiation-dependent spine enlargement requires synaptic Ca2 + -permeable AMPA receptors recruited by CaM-kinase I. J Neurosci 30(35):11565 -11575.
  22. [40]Shi SH, et al. (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 284(5421):1811 -1816.
  23. [41]Fein JA, et al. (2008) Co-localization of amyloid beta and tau pathology in Alzheimer ' s disease synaptosomes. Am J Pathol 172(6):1683 -1692.
  24. [42]Park ME, Horch P, Cotman CW (1978) Evaluation of glutamate as a hippocampal neurotransmitter: Glutamate uptake and release from synaptosomes. Brain Res 142(2):285 -299.
  25. [43]Fu Y, Huang ZJ (2010) Differential dynamics and activity-dependent regulation of alpha- and beta-neurexins at developing GABAergic synapses. Proc Natl Acad Sci USA 107(52):22699 -22704.
  26. [44]Bach ME, et al. (1999) Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci USA 96(9):5280 -5285.
  27. [45]Fouquet C, et al. (2011) Early detection of age-related memory deficits in individual mice. Neurobiol Aging 32(10):1881 -1895.
  28. [46]Griffin R, et al. (2006) The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 99(4):1263 -1272.
  29. [47]Bartfai T, et al. (2003) A low molecular weight mimic of the Toll/IL-1 receptor/ resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci USA 100(13):7971 -7976.
  30. [48]Kissner TL, et al. (2012) Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88. PLoS One 7(7):e40773.
  31. [49]Davis CN, et al. (2006) MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc Natl Acad Sci USA 103(8):2953 -2958.
  32. [51]Goshen I, et al. (2007) A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 32(8-10):1106 -1115.
  33. [52]Spulber S, et al. (2009) Impaired long term memory consolidation in transgenic mice overexpressing the human soluble form of IL-1ra in the brain. J Neuroimmunol 208(1-2): 46 -53.
  34. [55]Vereker E, O ' Donnell E, Lynch MA (2000) The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 20(18):6811 -6819.
  35. [56]Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5(8):629 -640.
  36. [57]Li Y, Liu L, Barger SW, Griffin WS (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23(5):1605 -1611.
  37. [59]Moraes CA, et al. (2015) Activated microglia-induced deficits in excitatory synapses through IL-1 β : Implications for cognitive impairment in sepsis. Mol Neurobiol 52(1): 653 -663.
  38. [60]Smith TD, Adams MM, Gallagher M, Morrison JH, Rapp PR (2000) Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. J Neurosci 20(17):6587 -6593.
  39. [61]Grant SG (2012) Synaptopathies: Diseases of the synaptome. Curr Opin Neurobiol 22(3):522 -529.
  40. [62]Selkoe DJ (2002) Alzheimer ' s disease is a synaptic failure. Science 298(5594):789 -791.
  41. [65]Griffin WS, et al. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86(19):7611 -7615.
  42. [66]Parnet P, Kelley KW, Bluthé RM, Dantzer R (2002) Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J Neuroimmunol 125(1-2):5 -14.
  43. [67]Srinivasan D, Yen JH, Joseph DJ, Friedman W (2004) Cell type-specific interleukin1beta signaling in the CNS. J Neurosci 24(29):6482 -6488.
  44. [68]Choi S, Friedman WJ (2009) Inflammatory cytokines IL-1 β and TNFα regulate p75NTR expression in CNS neurons and astrocytes by distinct cell-type-specific signalling mechanisms. ASN Neuro 1(2):e00010.
  45. [69]Booth RF, Clark JB (1978) A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain. Biochem J 176(2):365 -370.
  46. [70]Harrison DC, et al. (2000) The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia -caspase-3 as a case study. Brain Res Mol Brain Res 75(1):143 -149.
  47. [71]Taishi P, et al. (2012) Brain-specific interleukin-1 receptor accessory protein in sleep regulation. J Appl Physiol 112(6):1015 -1022.
  48. [72]Corera AT, Doucet G, Fon EA (2009) Long-term potentiation in isolated dendritic spines. PLoS One 4(6):e6021.
  49. [73]Park M, et al. (2006) Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes. Neuron 52(5):817 -830.
  50. [74]Chen RQ, et al. (2011) Role of glycine receptors in glycine-induced LTD in hippocampal CA1 pyramidal neurons. Neuropsychopharmacology 36(9):1948 -1958.

Cited by

Sorted by citations

Authors
Prieto, G. A., Snigdha, S., Baglietto-Vargas, D., Smith, E. D., Berchtold, N. C., Tong, L., Ajami, D., LaFerla, F. M., Rebek, J., & Cotman, C. W.
Affiliations
  • University of California, Irvine (US)
  • Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA 92697;
  • Scripps Research Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
2015-08-24
Volume
112
Issue
36
Pages
E5078-87
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2134486111
Cited by
126
References
10
Citations by year
2026: 9 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 5 · 2021: 19 · 2020: 11 · 2019: 9 · 2018: 26 · 2017: 11 · 2016: 6 · 2015: 1
FWCI
7.21
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by-nc-nd)
Funders
  • HHS | NIH | National Institute on Aging (P01-AG000538, RO1-AG34667, AG027544-06)
  • Larry L. Hillblom Foundation (#2013-A-016-FEL)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
IL-1β, IL-1 receptor type 1, IL-1 receptor accessory protein, synaptic plasticity, long-term potentiation, hippocampus, aging, neuroinflammation, cognitive impairment, lipopolysaccharide, memory
MeSH terms
Age Factors, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Hippocampus, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Synapses, Synaptosomes, Blotting, Western, Signal Transduction, Rats, Sprague-Dawley, Long-Term Potentiation, Brain-Derived Neurotrophic Factor, RNA Interference, Receptors, Interleukin-1 Type I, Interleukin-1 Receptor Accessory Protein, Interleukin-1beta, Mice, 129 Strain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review